Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture

BACKGROUND: While full disclosure of information on placebo control in participant information leaflets (PILs) in a clinical trial is ethically required during informed consent, there have been concerning voices such complete disclosures may increase unnecessary nocebo responses, breach double-blind...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheon, Soyeon, Park, Hi-Joon, Chae, Younbyoung, Lee, Hyangsook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774116/
https://www.ncbi.nlm.nih.gov/pubmed/29347917
http://dx.doi.org/10.1186/s12874-018-0474-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774116/
https://www.ncbi.nlm.nih.gov/pubmed/29347917
http://dx.doi.org/10.1186/s12874-018-0474-1

Ejemplares similares